Cited by — Sequencing analysis reveals evidence of immune activation in advanced HER2 negative breast cancer responders treated with the combination of entinostat, nivolumab, and ipilimumab | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Sequencing analysis reveals evidence of immune activation in advanced HER2 negative breast cancer responders treated with the combination of entinostat, nivolumab, and ipilimumab.
No admitted local citation edges point to this work yet.
